欧洲精品一区二区三区_欧美性性性性_国产一区二区免费在线播放_日日噜噜噜噜人人爽日本精品_无套中出丰满人妻无码_国产偷窥熟女精品视频大全

丹麥醫(yī)藥谷 Medicon Valley  
醫(yī)谷(Medicon　vally)是重要的特色集群機(jī)構(gòu)之一。1994年，北歐的丹麥和瑞典兩國政府聯(lián)手推動(dòng)在丹麥哥本哈根地區(qū)和瑞典南部，成立北歐地區(qū)第一個(gè)生技醫(yī)藥谷--Medicon Valley。丹麥醫(yī)藥谷與英國劍橋、瑞士巴塞爾并列為三大歐洲最佳生物科技創(chuàng)新基地，是丹麥生物技術(shù)產(chǎn)業(yè)群的先鋒，與大學(xué)院校、醫(yī)院和公司都有著密切的合作。醫(yī)藥谷包括丹麥的哥本哈根地區(qū)和瑞典南部的Skane地區(qū)，有320萬人口。與硅谷類似，醫(yī)藥谷的內(nèi)涵是技術(shù)、人才和資金的高密度積聚，在這里集中了大批醫(yī)院、大學(xué)、科學(xué)園和企業(yè)從事藥物、生物和醫(yī)學(xué)技術(shù)的研究和生產(chǎn)。


丹麥亦在中國上海設(shè)立了亞太地區(qū)丹麥投資促進(jìn)局（ ），丹麥投資促進(jìn)局（Invest in Denmark）隸屬于丹麥外交部貿(mào)易委員會(huì)，負(fù)責(zé)制定外商投資政策和管理外國企業(yè)在丹麥的投資事務(wù)，幫助來丹投資者提供咨詢和組建公司的一站式服務(wù)。無論外國公司在考慮選址、調(diào)整戰(zhàn)略布局、設(shè)立創(chuàng)新生產(chǎn)基地或是尋求技術(shù)創(chuàng)新的合作伙伴，以及其他戰(zhàn)略業(yè)務(wù)方案時(shí)，丹麥投資促進(jìn)局都能為其提供幫助和服務(wù)，并協(xié)助他們建立與丹麥公司及大學(xué)之間的合作。丹麥投資促進(jìn)局的專業(yè)服務(wù)覆蓋從公司有初步意向到業(yè)務(wù)設(shè)立完成，同時(shí)與公司保持進(jìn)一步的聯(lián)絡(luò)以確保外國投資者能夠充分享受丹麥優(yōu)越的投資環(huán)境。丹麥投資促進(jìn)局還為客戶提供信息保密，并提供專業(yè)且免費(fèi)的服務(wù)，包括全球基準(zhǔn)比較工具、針對客戶需求的商務(wù)考察等。



MEDICON VALLEY IS ONE OF EUROPE'S STRONGEST LIFE SCIENCE CLUSTERS. IT SPANS THE GREATER COPENHAGEN AREA IN DENMARK AND THE SK?NE REGION OF SOUTHERN SWEDEN.
Since the mid-1990s a fast-paced development has been taking place, and today Medicon Valley comprises a dense cluster of universities, hospitals and companies within life science, many of which are R&D based.

The history of Medicon Valley
Biotech is far from new to the region - in fact, some regard it as the cradle of biotech, thanks to the groundbreaking research that took place at the Carlsberg Breweries in Copenhagen in the late 1800's. Furthermore, many of the region's universities have a strong heritage in biological and medical research which have resulted in several Nobel Prize winners.

The almost century-long presence of a number of research-intensive and fully integrated pharmaceutical companies, such as Novo Nordisk, H. Lundbeck, AstraZeneca and LEO Pharma, have also contributed significantly to the development of the region by strengthening abilities within applied research, attracting suppliers and producing spin-offs.

In the mid-1990s the public authorities and the life science industry in Copenhagen and southern Sweden agreed to market the region internationally and to strive for a common goal: To be the most attractive bioregion in Europe.

Since 1997 Copenhagen Capacity and its Swedish counterpart Invest in Sk?ne have jointly branded the region as 'Medicon Valley' to reflect the region's life science strongholds, and today Medicon Valley is one of the strongest life science region in Europe.